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2Abstract20
The present study was conducted to investigate the effect of β-glucan (derived from 21
Sacharomyces cerevisiae) on the immune response and its protection against an 22
infection of the bacterial pathogen Aeromonas hydrophila in zebrafish (Danio rerio). 23
Zebrafish received β-glucan by intraperitoneal injection at three different concentrations24
(5, 2 and 0.5 mg/ml) at 6, 4 and 2 days prior the challenge. On challenge day the control 25
and β-glucan pretreated zebrafish were intraperitoneally injected with A. hydrophila and 26
mortality was recorded for 4 days. Intraperitoneal injection of 5 mg/ml of β-glucan 27
significantly reduced the mortality. A single injection of 5 mg/ml of β-glucan 6 days 28
before challenge also enhanced significantly the survival against the infection. The 29
treatment with β-glucan increased the myelomonocytic cells population from kidney at 30
6 hours postchallenge with A. hydrophila. Moreover it enhanced the ability of kidney 31
cells to kill A. hydrophila. β-glucan did not affect the expression of TNFα, IL1β but it 32
seemed to modulate the IFNγ and chemoquines expression in kidney.33
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3Introduction45
β-glucan is a heterogeneous group of glucose polymers, consisting of a backbone of β-46
(1→3)-linked β-D-glucopyranosyl units with β-(1→6)-linked side chains of varying 47
length and distribution. These polysaccharides are major cell wall structural components 48
in fungi and are also found in plants and some bacteria. β-glucan has been shown to be 49
immunostimulant and to posses an array of beneficial properties, including enhancing 50
protection against infections [1,2], tumour development [3,4] and sepsis [5,6]. 51
The effect of β-glucan has been attributed to its binding to several receptors on 52
leukocytes resulting in the stimulation of immune responses, such as bacteria killing 53
activity [2], modulation of cytokine production [7,8] and survival promotion at the cell, 54
organ and whole animal levels [8,9].55
Aeromonas spp. are ubiquitous inhabitants of aquatic ecosystems such as freshwater, 56
coastal water, and sewage [10]. They are increasingly being reported, especially 57
Aeromonas hydrophila, which is responsible for haemorrhagic septicemia, a disease 58
affecting a wide variety of freshwater fish species and occasionally marine fish [11-15]. 59
Furthermore, the bacterium is an emerging human pathogen that causes a variety of 60
diseases, most commonly gastroenteritis, wound infections and septicemia, in children 61
and adults [16,17]. 62
Several extracellular toxins and enzymes that may be associated with the virulence of A. 63
hydrophila such as hemolysins, cytotoxins, enterotoxins and proteases [18,19] have 64
been described. These virulence factors induce acute inflammatory responses [20,21] 65
enhancing the expression of genes encoding proinflammatory cytokines [22].66
The aim of this work was to investigate the effect of intraperitoneal injection of β-67
glucan on zebrafish, Danio rerio, experimentally infected with A. hydrophila. To study 68
this effect we examined the survival outcome in β-glucan treated infected zebrafish, the 69
4percentage of myelomonocytic cells from kidney cells, the bacteria killing ability and 70
the expression of proinflammatory cytokines.71
72
Materials and Methods73
Care and feeding of zebrafish followed established protocols [23] (also see 74
http://zfin.org/zf_info/zfbook/zfbk.html). Zebrafish wild type adults (1-1.5 g ; 4-5 cm) 75
were anesthetized with MS-222 (Tricaine methanesulfonate, Argent Chemical 76
Laboratories, USA). Euthanasia of zebrafish was obtained by an anaesthetic overdose. 77
The bacteria, isolated from zebrafish [24], were grown on tryptic soy agar (TSA) plates 78
for 24 h at RT and, after incubation, cells were recovered in sterile phosphate buffered 79
saline (PBS). Quantitation of logarithmic cultures was performed by spectrophotometry 80
and plating dilutions of the culture on TSA.81
For the challenge study, the ß glucan injections were performed as described by Selvaraj 82
et al. [2] Four groups (2 replicates of 12 zebrafish/group) were inoculated with 10 μl of 83
5, 2 or 0.5 mg/ml of β-glucan using a 0.5 ml [0.3 mm (30G) x 8 mm] syringe; 6, 4 and 2 84
days prior the inoculation of 10 μl from A. hydrophila (108 cfu/ml). Controls were 85
injected with 10 μl of PBS. The mortality was recorded daily up to 4 days.86
Another experiment was performed. Six groups (2 replicates of 12 zebrafish/group) 87
were pretreated by a single ip injection with 10 μl of 5 mg/ml of β-glucan or PBS at 2, 4 88
or 6 days prior to challenge. 89
To determine the changes in the percentage of myelomonocytic cells from kidney, 12 90
zebrafish were ip inoculated with 10 μl of β-glucan at a dose of 5 mg/ml and another 12 91
with PBS as was described above. On challenge day, 6 zebrafish from the β-glucan 92
group were ip inoculated with 10 μl of A. hydrophila at a dose of 108 cfu/ml and the 93
remaining 6 zebrafish were mock injected with PBS. After 6 hours, the kidneys of 94
5zebrafish of each group were removed aseptically and homogenised in two pools. Flow 95
cytometry analysis of the myelomonocytic cells population was based on forward and 96
side scatter on a FACScalibur flow cytometer (Beckton Dickinson) using previously 97
reported settings for the myelomonocytic cells population [24]. 98
The bacterial killing assay was performed according to Chen and Ainsworth [25]. Three 99
zebrafish were inoculated ip with 10 μl of PBS and another group of 3 zebrafish with 10 100
μl of 5 mg/ml of β-glucan as indicated in the challenge experiment description. On day 101
7 after the first inoculation, the kidney cells were obtained and suspended in D-102
MEM:F12 containing 10% foetal bovine serum (FBS) at a concentration of 5x105103
phagocytes/ml. From this, 0.1 ml was taken and mixed with 0.1 ml of A. hydrophila 104
(5x106 cfu/ml), mixed well and incubated for 2 hours with occasional shaking in a water 105
bath at 28ºC. After 2h, 0.1 ml of the bacteria/kidney cells mixture was diluted on 9.9 ml 106
of sterile distilled water to release living bacteria from phagocytes. This was serially 107
diluted, plated on TSA agar plates, incubated overnight at RT and the number of 108
colonies was counted.109
A group of 72 zebrafish was ip inoculated with β-glucan at a dose of 50 µg/fish and 110
another group of 72 animals with PBS to determine the tumor necrosis factor α (TNFα), 111
interleukin 1 β (IL1β) and interferon γ (IFNγ) expression. The fish in each experimental 112
treatment group (glucan or PBS) were redivided into two subgroups. Fish in a subgroup 113
were challenged with 10 μl of A. hydrophila at a dose of 108 cfu/ml, whereas fish in 114
another subgroup were mock infected with PBS by ip injection. After 30 min, 2, 4 and 115
6h of challenge, the kidneys were sampled and kept in Trizol. Three pools (3 116
zebrafish/pool) for each treatment and sample time were prepared. Briefly, RNA 117
extraction was performed using Trizol Reagent (Invitrogen). The reverse transcription 118
6was performed with the SuperScript II Reverse Transcriptase (Invitrogen) following the 119
manufacturer indications.120
Quantitative PCR assays were performed using the 7300 Real Time PCR System 121
(Applied Biosystems). cDNA amplification for –actin, TNFα, IL1β and IFNγ was 122
performed using specific primers described in [24] and the amplification of CXCL-C1c, 123
CC-chemokine and IL8 was performed using specific primers designed by Primer 3 124
software [26]. Primer sequences are shown in Table 1. Each primer (0.5 l with a 125
concentration of 10 M) was mixed with 12.5 l of SYBR green PCR master mix 126
(Applied Biosystems) in a final volume of 25 l. The standard cycling conditions were 127
95 º for 10 min, followed by 40 cycles of 95 º 15 s and 60 º for 1 min. The comparative 128
CT method (2-ΔΔCT method) was used to determine the expression level of analyzed 129
genes [27]. The expression of the candidate genes was normalized using –actin as a 130
housekeeping gene. Fold units were calculated dividing the normalized expression 131
values of infected tissues by the normalized expression values of the controls.132
Data were compared using the Student´s t-test. The results are expressed as mean ± 133
standard deviation and differences were considered significant at *P < 0.05.; ** P<0.01.134
135
Results and discussion136
Our results indicate that the mortality due to infection with A. hydrophila was reduced 137
by injecting different concentrations of β-glucan for three times at 6, 4 and 2 days prior 138
to challenge. The protective effect of ip injection of β-glucan against several infections 139
with pathogens has also been reported previously in different fish species [2, 28]. 140
However the group of fish injected with 5 mg/ml of β-glucan was the only group that 141
showed a significantly reduction of the mortality (figure 1A). A similar dose dependent 142
response to the ip injection with β-glucan has been also reported [2]. 143
7The single inoculation of 5 mg/ml of β-glucan at different days, 6, 4 or 2 prior to 144
challenge, showed that it enhanced the protection against bacterial infection; although 145
the inoculation 6 days prior to challenge was the only one that reduced significantly the 146
mortality (figure 1B). Similar results have been reported for brook trout (Salvelinus 147
fontinalis) in a challenge with Aeromonas salmonicida [29]. 148
The β-glucan pretreated zebrafish showed a percentage of myelomonocytic cells 149
significantly higher than the fish pretreated with PBS and although the infection with 150
bacteria reduced the population of myelomonocytic cells, the percentage of these cells 151
was still higher in the β-glucan pretreated zebrafish (figure 2A). These results are in 152
accordance with previous results [30] that showed that a derivative of glucan (PGG-153
glucan) enhanced human myelopoiesis. In mice, both intravenous and ip glucan 154
injection resulted in increased bone marrow proliferation [31, 32]. On the other hand 155
Jorgensen et al. [33] observed that 3 weeks after ip injection of glucan in salmon did not 156
produce changes in mean values of head kidney macrophages in both glucan and saline 157
treated salmon although the number of neutrophils increased significantly in the head 158
kidney of the glucan treated salmon. Furthermore the myelomonocytic cells increase 159
may be also explained by a priming effect for chemotaxis in circulating neutrophils to 160
the kidney [34]. 161
A. hydrophila was killed more efficiently by kidney cells of zebrafish inoculated with β-162
glucan than zebrafish inoculated with PBS. Bacterial count was significantly reduced in 163
glucan injected fish compared with the PBS injected fish after 2 h of incubation with 164
kidney cells (figure 2B). This increase of bactericidal activity has been previously 165
reported in carp [2].166
The mRNA expression levels of proinflammatory cytokines and chemokines were 167
determined by real time PCR in kidney of adult zebrafish pretreated with β-glucan or 168
8PBS at days 1, 3 and 5 and subsequently inoculated with A. hydrophila or mock infected 169
with PBS at day 7 for 30 min, 2, 4 and 6 hours (figure 3). 170
TNFα expression levels in Aeromonas injected zebrafish showed an increase over 171
control levels at 4 hours post-inoculation (hpi), this increase was even higher when the 172
zebrafish were pretreated with β-glucan. The β-glucan pretreated zebrafish and PBS 173
mock infected showed a slight induction at 6 hpi.174
IL1β expression levels had a 68 fold-induction at 2 hpi in PBS pretreated zebrafish and 175
infected with bacteria, they began to decline at 4 hpi. The zebrafish pretreated with β-176
glucan and infected with bacteria presented the same kinetics as the PBS group, 177
however the peak at 2 hpi was lower. The effect of pretreatment with β-glucan in mock 178
infected zebrafish was a minimal expression increase at 30 min and 2 hpi.179
The IFNγ expression levels of zebrafish pretreated with β-glucan and infected with 180
bacteria peaked at 4 hpi and they began to decline at 6 hpi, however the zebrafish 181
pretreated with PBS and infected with bacteria enhanced the expression levels at 6 hpi. 182
In the same way, the zebrafish pretreated with β-glucan and mock infected enhanced the 183
expression levels at 6 hpi.184
Concerning chemokines expression, we observed that in the zebrafish pretreated with 185
PBS and infected with bacteria the expression was lower than the fish infected and 186
pretreated with β-glucan, except for IL8 at 2 hpi, although in this case the standard 187
deviation was high. In fish pretreated with β-glucan and mock infected a weak 188
expression of CXCL-C1c and CC chemokine was observed.189
The β-glucan appears to be able to stimulate the production of proinflammatory 190
cytokines and chemokines, including TNFα, IL1β and IL8 [35].  Furthermore, this β-191
glucan is thought to modulate cytokine production to secondary challenge, but there are 192
9conflicting data as they have been shown to both prime and suppress these responses 193
[36, 37].194
In disagreement with our findings, Sener at al. [6] and Toklu et al. [38] showed reduced 195
TNFα levels following administration of β-glucan on animal model of sepsis, 196
suggesting that the protective capacity of β-glucans may be due to modulation of the 197
cytokine profile. However Engstad et al. [36] found that β-glucan primed LPS 198
stimulation of TNFα and that the β-glucan itself was also able to induce a minor amount 199
of TNFα. On the other hand, two and three copies of TNFα have been cloned in rainbow 200
trout and carp, respectively, which have been named as TNF-1α, TNF-2α and TNF-3α 201
[39-41]. Furthermore, in zebrafish a novel TNF gene (TNF-N) has been identified that 202
is present upstream of TNFα gene in the same transcriptional orientation [42]. Although 203
there is a progress in cloning of TNF genes from various fish species, not many 204
functional data exists on fish TNF genes. Therefore, we must take into account that the 205
presence of different copies of TNF may influence our results.206
Interestingly, the same situation occurs with IFNγ since in zebrafish two IFNγ genes 207
(IFNγ-1, IFNγ-2) have been identified and the expression analysis of these genes 208
suggests that they have an active role on immune responses in fish, where it was 209
showed that, while IFNγ-1 was expressed in normal tissues or treated with LPS and 210
Poly I:C, IFNγ-2 was expressed only after Poly I:C treatment [43]. In our case, we used 211
primers that amplified IFNγ-2 and it was observed that the expression increased earlier 212
in the zebrafish pretreated with β-glucan and infected with A. hydrophila than in PBS 213
pretreated fish. Furthermore, we found that β-glucan itself enhanced 18 fold the IFNγ 214
expression. Consequently, it seems that the β-glucan may modulate the expression of 215
IFNγ, which is a cytokine that is a strong activator of macrophages and the key of type 1 216
T helper (Th1) cell immune responses during infections with intracellular pathogens 217
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[44]; moreover, it can up-regulate the capacity of monocyte-derived macrophages to 218
phagocytose apoptotic cells [45]. Therefore, it seems that the immune cells could be 219
more active and have a reaction time faster against a challenge. However, this increase 220
of the expression of IFNγ does not seem sufficient to explain protection with β-glucan.221
The chemokines are a family of cytokines that induce the migration of cells to sites of 222
infection or injury in response to many stimulants, particularly proinflammatory 223
cytokines such as IL1 and TNF [46]. In our case, we observed that the higher expression 224
levels of chemokines mainly corresponded to fish pretreated with β-glucan and infected 225
with A. hydrophila. CXCL-C1c and CC chemokine were found in a SSH performed in 226
zebrafish infected with A. hydrophila for 1 hour and that enhanced their expression in 227
the kidney [Rodríguez, unpublished results]. Therefore, they might play important roles 228
in the response against the A. hydrophila infection. IL8 or CXCL8 are chemoattractive 229
to basophils, cytokine-stimulated eosinophils and peripheral blood T lymphocytes in 230
mammals [46]. In fish, it has been shown that trout CXCL8 expression is increased in 231
head kidney macrophages following exposure to LPS and recombinant human TNFα 232
[47]. Chemokines could be related with the increase in myelomonocytic cells through a 233
priming effect for chemotaxis in circulating neutrophils to the kidney.234
In summary, the literature on the effects of β-glucan on cytokine expression is 235
inconsistent, probably reflecting a complex biological interplay as well as the use of 236
different experimental systems and a variety of β-glucan preparations. Furthermore, in 237
fish multiple isoforms of cytokines are present, possible due to a genome duplication 238
event in bony fish [48]. These inconsistencies contribute to the enigma associated with 239
the mechanisms by which β-glucan protects against some bacterial infections.240
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Figure legends
Figure 1: A) Cumulative mortality percentage at 96 h postchallenge in adult zebrafish 
ip infected with 10 μl of A. hydrophila at a dose of 108 cfu/ml  that 6, 4 and 2 days prior 
to challenge were inoculated with 10 μl of PBS or 0.5, 2 and 5 mg/ml of β-glucan. B) 
Cumulative mortality percentage at 96 h post-challenge in adult zebrafish ip infected 
with 10 μl of A. hydrophila at a dose of 108 cfu/ml that 6, 4 or 2 days prior to challenge 
(dbc) were inoculated with 10 μl of PBS or 5 mg/ml of β-glucan. Each bar represents 
the mean of two duplicates. Error bars represents standard deviation. 
Figure 2: A) Percentage of myelomocytic cells measured by flow cytometry from 
kidney of zebrafish challenged with 10 μl of A. hydrophila at a dose of 108 cfu/ml for 6h 
and that were inoculated with 10 μl of PBS or β-glucan 5 mg/ml at 6, 4 and 2 days prior 
to challenge. Statistical difference between infected and mock infected zebrafish is 
given by (P<0.05). Statistical difference from control group (PBS pretreated) is given 
by ** (P<0.01). B) Bactericidal activity in kidney cells. Statistical difference from 
control group (PBS pretreated) is given by ** (P<0.01).  
Figure 3: Proinflammatory cytokines and chemokines expression levels in kidney cells 
from zebrafish challenged with 10 μl of A. hydrophila at a dose of 108 cfu/ml or mock 
infected with PBS for 30 min, 2, 4 and 6h and that were inoculated with 10 μl of PBS or 
β-glucan 5 mg/ml at 6, 4 and 2 days prior to challenge. Each point represents the mean 
of 3 pools (3 zebrafish/pool) for proinflammatory cytokines and 2 pools (3 
zebrafish/pool) for chemokines. Error bars represent standard deviation.
Table legends
Table 1: Sequences of oligonucleotide primers of CXCL-C1c, CC-chem and IL8.
Reviewers' comments:
Reviewer #1: 
1. Author should describe zebrafish size and weight.
The zebrafish size and weight is now described in line 73.
2. How much volume inject to zebrafish and also what kind of needle did you use?
The injected volume was added in several sentences and the type of needle used is 
described in line 82. 
3. In material and methods section the author should write about the expression 
analysis of TNF alpha, IL1beta, IFN gama (conditions of the real-time PCR)
This has been corrected (lines 115-130) 
4. In the results section the author should show the figure results of the flow 
cytometry analysis of the myelomonocytic cells population.
     
We believe that Figure 2A is enough to explain the results showing the percentages of 
the myelomonocytic cells population, because it clearly shows the effect of glucans and 
bacteria in the percentage of the myelomonocytic cells.
5. Page 4 lines 68, 92 and 94 <<myelomonocityc>> should be myelomonocytic
This has been corrected.
6. Page 15: figure 1 (A and B) and Page 16: figure 2C the author should change the 
white figure to other color.
This has been changed.
7. Two copies of TNF have been cloned in rainbow trout and carp, which have 
been named TNF-1alpha and TNF-2alpha (refer to Savan and Sakai, 2004). The 
author should make a comparison with TNF-1alpha and TNF-2alpha published.
The existence of different copies of TNF was commented (lines 198-204).
8. The author should compare the result of IFN gamma in the study with the two 
interferon (IFN) like gamma that has been reported refer to Savan and Sakai, 
2006).
It was also commented (lines 205-210).
* Response to Reviewers
9. The author should do expression analysis of chemotactic cytokines such as 
chemochines (CC and CXC) (refer to Laing and Secombes, 2004a) and other 
cytokines implicated in inflammation for example IL-18.
Additional experiments were conducted. The expression analysis of some chemokines 
was performed (CXCL-C1c, CC, IL8). This has been included in Material and Methods 
(lines 121-122) and also in Results and Discussion (lines 226-244).
Reviewer #2:
1. Line 25: Intraperitoneal injection of 5 mg/ml of <beta>-glucan. As long as the 
authors don´t state the volume of the injection it makes no sense. This lack of exact 
statement reduces the quality of  the manuscript.
This has been corrected.
2. The <beta>-glucan was injected intraperitoneally and the fish were shallenged 
by intraperitoneal injection of A. hydrophila. A better challenge-model is to 
challenge the fish by immersion (bathing) which is a more natural way of 
introducing infection to the fish.
The challenge immersion was not conducted because it does not cause mortalities 
unless induce a wound on the fish. (Rodríguez et al., Fish Shellfish Immunol 2008; 25: 
239-249.)
3. Below are listed line numbers that have to be amended with regard to statement 
of dose and not just concentration:
Lines: 23, 25, 26, 81/82, 82, 85, 87, 89, 96, 109, 123, 126, and legends to figures 1 
and 2.
This has been corrected.
4. Minor things. 
All the minor changes indicated by the referee have been corrected.
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Table 1 
 
Sequence Primers 5´-3´ 
 
Forward Reverse 
Nº accession 
GenBank 
CXCL-C1c CTGCTGCTTGCGGTAGTTTA TCAACTTTGTCGCAGTTTGG  NM_001115060 
CC-chem TGCAGCTCAACCAGAAGATG CTTTGACGCATGGAGGATTT BC162421.1 
IL8 GTCGCTGCATTGAAACAGAA CTTAACCCATGGAGCAGAGG XM_001342570.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
